Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1896-01-01

Employees: -

Market Cap: -

Website: https://www.bidmc.org/

Clinical Trials

Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)

Completed

Conditions: Ulcerative Colitis

First Posted Date: 2012-09-05

Last Posted Date: 2015-11-16

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 70

Registration Number: NCT01678300

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: Cisplatin
Drug: Cyclophosphamide
Drug: Doxorubicin

First Posted Date: 2012-08-22

Last Posted Date: 2025-04-09

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 118

Registration Number: NCT01670500

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

and more 12 locations

High-Dose Deferoxamine in Intracerebral Hemorrhage

Phase 2

Terminated

Conditions: Intracerebral Hemorrhage

Interventions: Drug: Normal saline
Drug: Deferoxamine

First Posted Date: 2012-08-13

Last Posted Date: 2019-06-12

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 42

Registration Number: NCT01662895

Locations: 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸
The Cleveland Clinic Foundation, Cleveland, Ohio, United States
🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States

and more 26 locations

Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism

Phase 2

Completed

Conditions: Sialorrhea

Interventions: Drug: Placebo
Drug: Incobotulinum Toxin A

First Posted Date: 2012-07-30

Last Posted Date: 2017-03-14

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 10

Registration Number: NCT01653132

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Enhancement of Brain Circuit of Inhibitory Control in Obese Patients Undergoing Gastric Banding

Not Applicable

Completed

Conditions: Obesity

Interventions: Device: Transcranial Direct Current Stimulation (tDCS)

First Posted Date: 2012-07-02

Last Posted Date: 2019-01-07

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 14

Registration Number: NCT01632280

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids

Not Applicable

Completed

Conditions: Metabolic Syndrome
Coronary Heart Disease

Interventions: Dietary Supplement: Omega 3 acid ethyl esters

First Posted Date: 2012-06-21

Last Posted Date: 2017-09-27

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 338

Registration Number: NCT01624727

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
South Shore Medical Group, Milton, Massachusetts, United States

Mindfulness Based Stress Reduction for Adults With Mild Cognitive Impairment

Not Applicable

Completed

Conditions: Mild Cognitive Impairment

Interventions: Behavioral: Mindfulness Based Stress Reduction (MBSR)

First Posted Date: 2012-05-24

Last Posted Date: 2012-05-24

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 14

Registration Number: NCT01605448

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Scribes in the Emergency Department

Withdrawn

Conditions: Scribes in the Emergency Department

First Posted Date: 2012-05-16

Last Posted Date: 2017-01-05

Lead Sponsor: Beth Israel Deaconess Medical Center

Registration Number: NCT01599910

Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)

Phase 2

Withdrawn

Conditions: Parkinson Disease
Amyotrophic Lateral Sclerosis

Interventions: Drug: Incobotulinum Toxin A
Drug: placebo

First Posted Date: 2012-03-28

Last Posted Date: 2017-02-07

Lead Sponsor: Beth Israel Deaconess Medical Center

Registration Number: NCT01565395

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI

Phase 4

Completed

Conditions: Hunger
Diabetes
Effects of Liraglutide Administration on Brain Activity
Weight Loss

Interventions: Drug: Liraglutide
Drug: Placebo

First Posted Date: 2012-03-26

Last Posted Date: 2017-05-31

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 28

Registration Number: NCT01562678

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy